Literature DB >> 10930448

Evidence for angiotensin II type 2 receptor-mediated cardiac myocyte enlargement during in vivo pressure overload.

T Senbonmatsu1, S Ichihara, E Price, F A Gaffney, T Inagami.   

Abstract

The pathophysiological roles of the angiotensin II type 2 receptor (AT(2)) in cardiac hypertrophy remain unclear. By the targeted deletion of mouse AT(2) we were able to prevent the left ventricular hypertrophy resulting from pressure overload, while cardiac contractile functions remained normal. This implies that AT(2) is a mediator of cardiac hypertrophy in response to increased blood pressure. The effects of AT(2) deletion were independent of activation of embryonic genes for cardiac hypertrophy. However, p70(S6k), one of the key factors in cardiac hypertrophy, was markedly and specifically reduced in the ventricles of Agtr2(-)/Y mice. We propose that p70(S6k) plays a major role in AT(2)-mediated ventricular hypertrophy. This article may have been published online in advance of the print edition. The date of publication is available from the JCI website, http://www.jci.org.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10930448      PMCID: PMC314331          DOI: 10.1172/JCI10037

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  29 in total

1.  Loss of a gp130 cardiac muscle cell survival pathway is a critical event in the onset of heart failure during biomechanical stress.

Authors:  H Hirota; J Chen; U A Betz; K Rajewsky; Y Gu; J Ross; W Müller; K R Chien
Journal:  Cell       Date:  1999-04-16       Impact factor: 41.582

Review 2.  Regulation of growth in the adult cardiomyocytes.

Authors:  K D Schlüter; H M Piper
Journal:  FASEB J       Date:  1999       Impact factor: 5.191

3.  Chronic N(G)-nitro-L-arginine methyl ester-induced hypertension : novel molecular adaptation to systolic load in absence of hypertrophy.

Authors:  J Bartunek; E O Weinberg; M Tajima; S Rohrbach; S E Katz; P S Douglas; B H Lorell
Journal:  Circulation       Date:  2000-02-01       Impact factor: 29.690

4.  In vitro RNA synthesis with SP6 RNA polymerase.

Authors:  P A Krieg; D A Melton
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

5.  A calcineurin-dependent transcriptional pathway for cardiac hypertrophy.

Authors:  J D Molkentin; J R Lu; C L Antos; B Markham; J Richardson; J Robbins; S R Grant; E N Olson
Journal:  Cell       Date:  1998-04-17       Impact factor: 41.582

6.  Pressure overload induces cardiac hypertrophy in angiotensin II type 1A receptor knockout mice.

Authors:  K Harada; I Komuro; I Shiojima; D Hayashi; S Kudoh; T Mizuno; K Kijima; H Matsubara; T Sugaya; K Murakami; Y Yazaki
Journal:  Circulation       Date:  1998-05-19       Impact factor: 29.690

7.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

8.  Compliance of the left ventricle.

Authors:  H J Levine
Journal:  Circulation       Date:  1972-09       Impact factor: 29.690

9.  Demonstration of different metal ion-induced calcineurin conformations using a monoclonal antibody.

Authors:  H Matsui; C J Pallen; A M Adachi; J H Wang; P H Lam
Journal:  J Biol Chem       Date:  1985-04-10       Impact factor: 5.157

10.  Regression of left ventricular hypertrophy and prevention of left ventricular dysfunction by captopril in the spontaneously hypertensive rat.

Authors:  J M Pfeffer; M A Pfeffer; I Mirsky; E Braunwald
Journal:  Proc Natl Acad Sci U S A       Date:  1982-05       Impact factor: 11.205

View more
  32 in total

Review 1.  Knockout of renin-angiotensin system genes: effects on vascular development.

Authors:  D Methot; T L Reudelhuber
Journal:  Curr Hypertens Rep       Date:  2001-02       Impact factor: 5.369

2.  Serial killer: angiotensin drives cardiac hypertrophy via TGF-beta1.

Authors:  Michael D Schneider
Journal:  J Clin Invest       Date:  2002-03       Impact factor: 14.808

Review 3.  Angiotensin AT2 receptors: cardiovascular hope or hype?

Authors:  Robert E Widdop; Emma S Jones; Ruth E Hannan; Tracey A Gaspari
Journal:  Br J Pharmacol       Date:  2003-10-06       Impact factor: 8.739

4.  Is there a link between angiotensin receptor blockers and cancer?

Authors:  Frank Enseleit; Frank Ruschitzka
Journal:  Curr Hypertens Rep       Date:  2011-02       Impact factor: 5.369

Review 5.  International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected].

Authors:  Sadashiva S Karnik; Hamiyet Unal; Jacqueline R Kemp; Kalyan C Tirupula; Satoru Eguchi; Patrick M L Vanderheyden; Walter G Thomas
Journal:  Pharmacol Rev       Date:  2015-10       Impact factor: 25.468

6.  Mast cell chymase limits the cardiac efficacy of Ang I-converting enzyme inhibitor therapy in rodents.

Authors:  Chih-Chang Wei; Naoki Hase; Yukiko Inoue; Eddie W Bradley; Eiji Yahiro; Ming Li; Nawazish Naqvi; Pamela C Powell; Ke Shi; Yoshimasa Takahashi; Keijiro Saku; Hidenori Urata; Louis J Dell'italia; Ahsan Husain
Journal:  J Clin Invest       Date:  2010-03-24       Impact factor: 14.808

Review 7.  The vasoprotective axes of the renin-angiotensin system: Physiological relevance and therapeutic implications in cardiovascular, hypertensive and kidney diseases.

Authors:  Xiao C Li; Jianfeng Zhang; Jia L Zhuo
Journal:  Pharmacol Res       Date:  2017-06-12       Impact factor: 7.658

8.  Cardioprotective effect of thyroid hormone is mediated by AT2 receptor and involves nitric oxide production via Akt activation in mice.

Authors:  Ivson Bezerra da Silva; Dayane Aparecida Gomes; Natalia Alenina; Michael Bader; Robson Augusto Dos Santos; Maria Luiza M Barreto-Chaves
Journal:  Heart Vessels       Date:  2017-12-07       Impact factor: 2.037

Review 9.  Molecular mechanisms of angiotensin II-induced vascular injury.

Authors:  Marta Ruiz-Ortega; Monica Ruperez; Vanesa Esteban; Jesús Egido
Journal:  Curr Hypertens Rep       Date:  2003-02       Impact factor: 5.369

10.  A novel angiotensin II type 2 receptor signaling pathway: possible role in cardiac hypertrophy.

Authors:  Takaaki Senbonmatsu; Takako Saito; Erwin J Landon; Otsu Watanabe; Edward Price; Richard L Roberts; Hans Imboden; Trinita G Fitzgerald; F Andrew Gaffney; Tadashi Inagami
Journal:  EMBO J       Date:  2003-12-15       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.